Humana maintains FY26 adjusted EPS guidance of at least $9. No change to previous financial targets disclosed in SEC filing. Reaffirmation signals stable operational outlook for the insurer.

Maple Rock Capital Partners Inc. lifted its stake in Humana Inc. (NYSE:HUM - Free Report) by 82.2% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 628,251 shares of the insurance provider

Two Sigma Securities LLC bought a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 3,067 shares of the insurance provider

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 2.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,072,296 shares of the insuran

Wellington Management Group LLP lifted its holdings in Humana Inc. (NYSE:HUM - Free Report) by 7.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 765,355 shares of the insurance provider

Beaconlight Capital LLC bought a new position in Humana Inc. (NYSE:HUM - Free Report) in the second quarter, according to its most recent disclosure with the SEC. The firm bought 8,220 shares of the insurance provider

Rakuten Investment Management Inc. bought a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 19,637 shares of the insurance provider